NCT06986616

Brief Summary

The aim of this observational study is to whether fibroids increase the risk of miscarriage in women in our early pregnancy population. We will be collecting lots of data detailing other factors, which may have an impact on overall health and on the risk of miscarriage (this includes age, weight, use of vitamins or progesterone supplements, postcode which is linked to national deprivation scoring status and employment status). By collecting all this data, we hope to remove the effect of other factors and purely assess the effect that the fibroids have on the outcome in early pregnancy. We will also be looking closely at whether the location, number or size of the fibroids can affect the pregnancy too and following up women at 24 weeks via phone. We will also look at other secondary outcomes such whether women with fibroids experience symptoms of pain or bleeding in the first or second trimester more so than their control counterparts. We will also look at the value of uterine volume as a surrogate marker of fibroid mapping. Once all the data has been analysed, we will be able to assess whether fibroids lead to an increased risk of miscarriage. We hope that this information will be useful in counselling women affected by fibroids in the pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
436

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 9, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

May 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

May 15, 2025

Last Update Submit

May 15, 2025

Conditions

Keywords

fibroidmiscarriage

Outcome Measures

Primary Outcomes (1)

  • Miscarriage prior to 24 weeks

    Miscarriage prior to 24 weeks - or delivery prior to 24 weeks

    From enrollment to the end of data collection (data would be collected from 24 weeks)

Secondary Outcomes (3)

  • Risk of miscarriage based on fibroid characteristics

    From enrollment until data colelction (from 24 weeks)

  • Risk of miscarriage according to trimester

    From enrollment to end of data collection (from 24 weeks)

  • Presence of symptoms of pain or bleeding and association with fibroids and trimester

    From enrollment to end of data collection (from 24 weeks)

Other Outcomes (1)

  • Uterine volume and value as a surrogate marker for fibroid mapping

    From enrollment to end of data collection (from 24 weeks onwards).

Study Arms (2)

Cases - fibroids

Women with fibroids

Controls - no fibroids

Women without fibroids

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women attending the early pregnancy unit in our London hospital will be the target population.

You may qualify if:

  • All women presenting at less than 10 weeks gestation either by last menstrual period or by transvaginal scan findings with an early intrauterine or ongoing pregnancy on scan

You may not qualify if:

  • Women declining participation and follow up
  • Women wishing to pursue termination of pregnancy
  • Women who refuse transvaginal scan
  • Multiple pregnancy
  • Ectopic pregnancy
  • Pregnancy of unknown location
  • Embryonic demise
  • Under 16
  • Unable to understand - interpreting services will be used such as language line if required.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Early Pregnancy and Gynaecology Assessment Unit, King's College Hospital NHS Foundation Trust

London, London, SE5 9RS, United Kingdom

Location

MeSH Terms

Conditions

LeiomyomaAbortion, Spontaneous

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2025

First Posted

May 23, 2025

Study Start

January 9, 2019

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Data is available for reasonable requests including study protocol and anonymised data.

Locations